ProfileGDS2244 / 201004_at
TitleMelanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OrganismHomo sapiens


E2F-1 doxorubicin E2F-1 and doxorubicin GSM52504 GSM52508 GSM52518 GSM52519 GSM52516 GSM52517 95% 96% 96% 96% 96% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM52504SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1)100095
GSM52508SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2)1241.996
GSM52518SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1)1347.696
GSM52519SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2)1259.796
GSM52516SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1)1213.196
GSM52517SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2)1115.196